MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions
View by Date
Jump to:  View All • a b c d e f g [h] i j k l m n o p q r s t u v w x y z
  • Harmonics: A reliable marker in tremor analysis for the differential diagnosis of Parkinson’s disease and multiple system atrophy

    D. Su, S. Yang, J. Zhou, H. Pan, T. Feng (Beijing, China)

  • Health associated quality of life (HAQL) and humor/cognitive complaints predict mortality in Parkinson’s disease (PD)

    P. Bugalho, R. Barbosa, F. Ladeira, J. Marto, C. Borbinha, L. Conceição, M. Saraiva, M. Salavisa, B. Meira, M. Fernandes (Lisbon, Portugal)

  • Health-related quality of life in cervical dystonia; the hidden and unaddressed effect of anxiety

    I. Ndukwe, P. Lynch, J. Dover, C. O’Neill, F. O’Keeffe, S. O'Riordan, M. Hutchinson (Dublin, Ireland)

  • Healthcare disparities in patients with Parkinson’s disease: A comprehensive literature review and call to action

    S. Naik, V. Holiday, L. Dixon, M. Kolikonda, K. Lafaver (Louisville, KY, USA)

  • Healthcare Resource Utilization and Costs of Parkinson’s Disease Dementia With Psychosis in the US Medicare Population

    J. Wetmore, H. Yan, M. Irfan, Y. Peng, D. Gilbertson, S. Li, N. Rashid, A. Shim (Minneapolis, MN, USA)

  • Healthcare utilization and emergency department/inpatient costs in adult and pediatric functional neurological disorders

    C. Stephen, C. Lungu, A. Espay (Boston, MA, USA)

  • Heart Rate Variability and Cognitive Impairment in Parkinson’s Disease

    C. Terroba-Chambi, D. Vigo, M. Merello (Caba, Argentina)

  • Heavy metals implicated in a geographical cluster of progressive supranuclear palsy induce tau accumulation and apoptotic cell death in cultured neurons

    C. Alquezar, J. Felix, E. Mccandlish, B. Buckley, D. Caparros-Lefebvre, C. Karch, L. Golbe, A. Kao (San Francisco, CA, USA)

  • Hemi masticatory spasm (HMS) : Series of 7 cases

    D. Radhakrishnan, V. Goyal, G. Shukla, M. Singh (New Delhi, India)

  • Hemiballismus-hemichorea due to ischemic stroke

    AM. Magnerou, PE. Sounga Bandzouzi (Douala, Cameroon)

  • Hemichorea revealing a putaminal cavernous angioma

    Y. Mecheri, F. Serradj, BS. Fekraoui, A. Hamri (Constantine, Algeria)

  • Hemifacial Involvement in a Patient with Oculopalatal Tremor Due to Inferior Olivary Hypertrophy

    C. Gill, M. Bailey (Chicago, IL, USA)

  • Hemifacial Spasm and Related Comorbidities

    A. Akyol Gurses, N. Kiylioglu, A. Akyol (Aydin, Turkey)

  • Hemifacial spasm management: 26-year experience

    Y. Herrero-Infante, A. Rodriguez-Sanz, J. Mañez-Miró, F. Vivancos-Matellano (Madrid, Spain)

  • Hemispheric Differences in Motor Circuitry of Parkinson’s disease: Metabolism and Micro-Structure

    DAN. Stein, N. Goldberg, L. Domachevsky, H. Bernstine, M. Nidam, D. Groshar, M. Lorberboym, S. Israeli-Korn, M. Gomori, Y. Assaf, S. Hassin-Baer (Tel-Aviv, Israel)

  • Hereditary and geneological aspects of Parkinson’s disease and essential tremor in people of Uzbek nationality

    R. Matmurodov, K. Khalimova (Tashkent, Uzbekistan)

  • Hereditary spastic paraplegia 11 is easy to be misdiagnosed as adult metachromatic leukodystrophy

    S. Park, AR. Kim, N. Kim, WY. Park, JS. Kim, ES. Oh (Seoul, Republic of Korea)

  • Heterogeneous patterns of striatal dopamine loss in patients with young- versus old-onset Parkinson’s disease

    NE. Woo, SJ. Chung, HS. Yoo, YH. Lee, PH. Lee, YH. Sohn (Seoul, Republic of Korea)

  • Heterozygous DCC mutations, more than congenital mirror movements

    S. Thams, M. Islam, M. Lindefeldt, A. Nordgren, T. Granberg, D. Nilsson, M. Paucar (Stockholm, Sweden)

  • HGprt deficiency affects early brain development in vivo in a mouse model of Lesch-Nyhan disease

    J. Witteveen, S. Loopstok, L. Luque Ballesteros, A. Boonstra, N. van Bakel, W. van Boekel, G. Martens, J. Visser, S. Kolk (Nijmegen, Netherlands)

  • HGprt deficient brain RNA expression patterns reveal specific abnormalities related to neuronal function in a mouse model of Lesch-Nyhan disease.

    J. Visser, C. Klemann, G. Martens (Nijmegen, Netherlands)

  • High Content Screening of synucleinopathy in primary cortical neurons : dissecting out the interplay between the basic synuclein pools

    F. de Giorgi, E. Bezard, F. Ichas (Bordeaux, France)

  • High cost of medications for Parkinson’s Disease patients in a rural population of Gujarat, India

    A. Pandya, E. Albert-Stone, A. Deb, S. Desai (Worcester, MA, USA)

  • High dose amantadine therapy may cause increased falling in Parkinson’s patients

    L. Verhagen Metman (Chicago, IL, USA)

  • High Dose Botulinum Toxin Therapy: Safety, Benefit and Endurance of Efficacy

    S. Chiu, B. Patel, M. Burns, J. Legacy, A. Shukla, A. Ramirez-Zamora, W. Deeb, I. Malaty (Gainesville, FL, USA)

  • High dose off-label Safinamide treatment in Young Onset Parkinson’s Disease patients

    C. Carrarini, M. Russo, F. Barbone, F. Dono, M. Rispoli, M. Onofrj, A. Thomas (Chieti, Italy)

  • High intensity interval training elevates circulating BDNF and miRNAs level in patients with idiopathic Parkinson’s disease

    P. Malczynska, B. Kaminski, M. Siemiatycka, A. Pawłowska, I. Przybylska, J. Langfort, J. Marusiak, M. Chalimoniuk (Warsaw, Poland)

  • High rate of mutations in complex dystonia revealed by exome sequencing

    T. Wirth, C. Tranchant, N. Drouot, B. Keren, L. Cif, C. Mignot, R. Lefaucheur, L. Lion-François, A. Méneret, D. Gras, E. Flamand-Roze, C. Laroche, P. Burbaud, S. Bannier, O. Boukbiza, MA. Spitz, V. Laugel, M. Bereau, D. Doummar, G. Rudolf, M. Anheim, J. Chelly (Illkirch-Graffenstaden, France)

  • High repressive activity of olive extracts on the cell line model of Parkinson disease against ROS induction

    D. Morshedi (Tehran, Islamic Republic of Iran)

  • High-Beta and High-Gamma Power Oscillations from Subthalamic Nucleus distinguishes Parkinson’s Disease Subtypes

    F. Godinho, J. Luccas, B. Bianqueti, A. Fim Neto, T. Almeida, MS. Rocha, T. Yoneyama, D. Soriano (São Bernardo, Brazil)

  • High-throughput screening using a Drosophila model of Parkinson’s disease

    FJ. Lopez, C. Solana, E. Masia, MJ. Vicent, N. Paricio (Valencia, Spain)

  • Higher levels of physical activity is associated with fewer non-motor symptoms in early Parkinson’s disease: a 1-year follow-up study

    S. Ng, N. Chia, M. Abbas, KY. Tay, WL. Au, EK. Tan, L. Tan (Singapore, Singapore)

  • Higher probability of prodromal Parkinson’s disease is related to lower performance in all cognitive domains

    A. Bougea, M. Maraki, M. Yannakoulia, M. Stamelou, G. Xiromerisiou, M. Kosmidis, E. Dardiotis, G. Hadjigeorgiou, P. Sakka, C. Anastasiou, L. Stefanis, N. Scarmeas (Athens, Greece)

  • Hip fracture in patients with a new diagnosis of Parkinson’s Disease – estimating the 5-year risk

    L. Evans, A. Johansen, B. Mohamed, EC. Thomas (Cardiff, United Kingdom)

  • Hippotherapy for axial symptoms, gait and posture in people with Parkinson disease: A case report

    T. Mcisaac, J. Hayes, J. Goodman, O. Harpham, N. Erickson (Mesa, AZ, USA)

  • Holmes Tremor : contribution of Botulinum toxin injection strategy guided by electromyographic (EMG) polygraphic recording

    F. Jomier, Y. Beaugendre Ahmar, E. Apartis, D. Grabli (Paris, France)

  • Homozygous BZRAP1 mutations cause autosomal recessive dystonia

    NE. Mencacci, MM. Brockmann, S. Pajusalu, B. Atasu, P. Gonzalez-Latapi, M. Schwake, B. Balint, A. Papandreou, A. Pittman, J. Simon-Sanchez, S. Wiethoff, TT. Warner, T. Gasser, M. Kurian, E. Lohmann, K. õunap, KP. Bhatia, C. Rosenmund, T. Sudhof, NW. Wood, D. Krainc, C. Acuna Goycolea (Chicago, IL, USA)

  • Homozygous Huntington’s disease with two reduced penetrance alleles: A Case Report

    K. Grimm, C. Zühlke, C. Gerloff, S. Zittel (Hamburg, Germany)

  • Hoover’s Sign in Parkinson’s Disease

    A. Vasilenko, M. Karpova (Chelyabinsk, Russian Federation)

  • How cognitive effort increases Parkinson’s tremor – an effictive connectivity fMRI study

    MF. Dirkx, H. Zach, A. van Nuland, BR. Bloem, I. Toni, R. Helmich (Nijmegen, Netherlands)

  • How Commonly Does Parkinson’s Disease Present with Dystonia?

    P. Popa, C. Brown, C. Henchcliffe, H. Sarva (New York, NY, USA)

  • How Parkinson’s Disease Affects Value-Based Decisions

    L. Montaser-Kouhsari, R. Gerraty, A. Bakkour, D. Shohamy (New York, NY, USA)

  • How reliable are non-blinded evaluations of motor UPDRS? a comparison of blinded vs. un-blinded UPDRS scores in 14 patients with advanced Parkinson´s disease

    G-M. Hariz, A. Fredricks, R. Stenmark, J. Linder, M. Hariz, L. Forsgren, P. Blomstedt (Umea, Sweden)

  • Humming bird sign in craniovertebral junction anomaly leading to misdiagnosis of progressive supranuclear palsy

    D. Desai, D. Pandya, S. Desai (Anand, India)

  • Huntington Disease-Like 2: A Case Presentation and Review of the Literature

    J. Pleen, V. Saini, N. Doher, R. Walker, V. Singh (Kansas City, KS, USA)

  • Huntington’s Disease Protein Huntingtin Associates with its own mRNA

    M. Rakhimova, M. Daropova (Tashkent, Uzbekistan)

  • Huntington’s Disease presenting as sporadic cerebellar ataxia

    GLF. Franklin, FAN. Nascimento, GMP. Pavanelli, SSM. Milano, HAT. Teive, NSL. Lima, SR. Raskin (Curitiba, Brazil)

  • Huntington’s disease: A case review of Sub-Saharan Africans with diverse origins

    M. Muthinja, J. Hooker (Nairobi, Kenya)

  • Hydralazine protects nigrostriatal dopaminergic neurons from MPP+ and MPTP induced neurotoxicity: Roles of Nrf2-ARE signaling pathway

    XF. Guo, T. Wang, J. Huang, N. Xiong, C. Han, K. Ma, Y. Xia, F. Wan, JJ. Hu, SJ. Yin, L. Kou, YD. Sun, JW. Wu (Wuhan, China)

  • Hydrocephalic presentation of PSP and follow-up after ventricular-peritoneal shunting: Case report

    A. Taskinbayeva, CH. Shashkin, R. Kaiyrzhanov (Almaty, Kazakhstan)

  • Hyperammonemic Encephalopathy as Primary Cause of Movement Disorders: Report of Two Cases

    G. Fabiani, FMB. Germiniani, S. Raskin, HAG. Teive (Curitiba, Brazil)

  • Hyperkinetic Movement Disorders in Congenital Disorders of Glycosylation

    G. Mostile, R. Barone, A. Nicoletti, R. Rizzo, D. Martinelli, L. Sturiale, A. Fiumara, J. Jankovic, M. Zappia (Catania, Italy)

  • Hypermethylation of PGC-1α in peripheral blood leukocytes of patients with Parkinson’s disease

    X. Yang, SQ. Xu, W. Qian, Q. Xiao (Shanghai, China)

  • Hypophosphatasia presenting as parkinsonism with compound heterozygous mutations in ALPL gene

    WF. Yu, ZX. Zhao, LW. Liu, JL. Hu, FF. Wang, YM. Liu (Jinan, China)

  • Hyposmia as a marker of (non-)motor disease progression in Parkinson’s disease

    D. Roos, J. Twisk, P. Raijmakers, R. Doty, H. Berendse (Amsterdam, Netherlands)

  • Hypothalamic functional connectivity correlates with autonomic symptom burden in patients with Multiple System Atrophy

    M. Sklerov, N. Browner, D. Drazheva, E. Dayan (Chapel Hill, NC, USA)

Jump to:  View All • a b c d e f g [h] i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Safety and Tolerability of a Ketone Supplement in Parkinson's Disease
  • Successful external defibrillation in a patient with bilateral deep brain stimulation
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley